Bio Path Holdings Inc expected to post a loss of $5.40 a share - Earnings Preview

Bio Path Holdings

06/03/2024 13:34

* Bio Path Holdings Inc  BPTH.OQ   BPTH.O  is expected
to show no
change in quarterly revenue when it reports  results on March 8
for the period ending December 31 2023
    * 
    * ​LSEG's mean analyst estimate for Bio Path Holdings Inc is
for a
loss of $5.40 per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Bio Path
Holdings
Inc is $240.00​, above​ its last closing price of $6.31. ​​​

This summary was machine generated March 6 at 13:34 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)